Madeleine Wetzel
Medical · Philadelphia, PANPI 1760140040
Payments from drug & device makers
Across 469 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$916
- AstraZeneca$615
- Teva Pharmaceuticals USA, Inc.$591
- Axsome Therapeutics, Inc.$471
- Novo Nordisk$432
- plus $4K from 31 others
What the payments were for
- Food & beverage$8,124100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 137 | $1,474 |
| Lilly USA, LLC | 36 | $916 |
| AstraZeneca | 32 | $615 |
| Teva Pharmaceuticals USA, Inc. | 34 | $591 |
| Axsome Therapeutics, Inc. | 21 | $471 |
| Novo Nordisk | 27 | $432 |
| GSK | 17 | $370 |
| Boehringer Ingelheim | 15 | $318 |
| Astellas Pharma US Inc | 16 | $310 |
| Sumitomo Pharma America, Inc. | 16 | $310 |
| Pfizer | 13 | $255 |
| Otsuka America Pharmaceutical, Inc. | 10 | $223 |
| Bayer | 10 | $199 |
| Collegium Pharmaceutical, Inc. | 11 | $198 |
| Exact Sciences | 7 | $150 |
| Amgen | 7 | $150 |
| Kowa Pharmaceuticals America, Inc. | 9 | $140 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $124 |
| Lundbeck LLC | 5 | $100 |
| Johnson & Johnson | 4 | $93 |
| Neurocrine Biosciences, Inc. | 5 | $88 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $62 |
| Almatica Pharma LLC | 3 | $59 |
| Verona Pharma, Inc. | 2 | $58 |
| Urovant Sciences Inc | 4 | $51 |
| Indivior Inc. | 2 | $48 |
| Braeburn Inc. | 2 | $46 |
| Avanir Pharmaceuticals, Inc. | 2 | $44 |
| Merck | 3 | $44 |
| Corium, LLC | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| Acerus Pharmaceuticals Corporation | 1 | $24 |
| Dexcom, Inc. | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Theracosbio, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$242
How this compares
$8,124 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 12 | $19,777 |
| FarxigaDapagliflozin Propanediol | 11 | $16,584 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $14,737 |
| EliquisApixaban | 13 | $8,623 |
| Atorvastatin Calcium | 67 | $1,025 |
| Valsartan | 23 | $954 |
| Levothyroxine Sodium | 40 | $780 |
| Rosuvastatin Calcium | 36 | $729 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $661 |
| Duloxetine Hcl | 18 | $625 |
| Celecoxib | 11 | $574 |
| Amlodipine Besylate | 82 | $541 |
| Omeprazole | 31 | $470 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $408 |
| Oxycodone Hcl | 25 | $400 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $916 | $19,77712 claims |
| AstraZenecaFarxiga | $615 | $16,58411 claims |
| GSKTrelegy Ellipta | $370 | $14,73711 claims |
| PfizerEliquis | $255 | $8,62313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.
Other medical in Philadelphia
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Sarah SmithPhiladelphia$65K
- Victoria WongPhiladelphia$51K
- Parth PatelPhiladelphia$46K
- Zachary LutzPhiladelphia$30K
- Hawah MusaPhiladelphia$13K
- Carl BlackPhiladelphia$13K
- Ashley BarratPhiladelphia$12K
- Jacqueline KernaghanSpringfield$427K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.